Skip to main content

Advertisement

SpringerLink
Log in

Screening for depression in movement disorders clinic

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Depression is the most common, though often under-recognised, neuropsychiatric disturbance in movement disorders (MD).

Objective

This study aimed to establish whether a briefer screening measure such as a visual analogue screening measure (Emotions Thermometer) or Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) could be a potentially suitable screening tool for depression in MD patients.

Method

Patients attending a regional MD outpatient clinic completed the Emotional Thermometer 7-item tool (ET7), the Hospital Anxiety and Depression Scale (HADS) and the Neurological Disorders Depression Inventory for Epilepsy (NDDIE). We used the Major Depression Inventory which provided the diagnosis of depression based on ICD-10 and DSM-IV as our diagnostic gold standard to compare the performance of ET7 and its individual sub-scales, its briefer version ET4, HADS, and NDDIE. Sensitivity, specificity, positive predictive value, negative predictive value and receiver operating characteristic curves were calculated to compare the performance of the screening tools.

Results

In total, 188 patients were included in the analysis. The most accurate tools as determined by Receiver Operating Characteristics curve were HADS-D for ICD-10 depressive episode and DepT for DSM-IV major depression. ET4 performed well as a ‘rule-out’ screening tool for both DSM-IV and ICD-10 depression. ET4 performance was comparable to HADS without the need for clinician scoring. The briefer ET4 performed almost as well as ET7.

Conclusion

Emotions Thermometer and NDDI-E are quick and reliable screening tools for depression in the MD population and are comparable to HADS. We suggest routine use of visual analogue ET4 as it is briefer, requires less time to complete and does not require scoring from the clinicians. It has the potential to be widely implemented across busy neurology clinics to assist in depression screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ketharanathan T, Hanwella R, Weerasundera R, Silva VAD (2014) Major depressive disorder in Parkinson’s disease: a cross-sectional study from Sri Lanka. BMC Psychiatry 14(1):278

    Article  Google Scholar 

  2. McDonald WM, Richard I, DeLong MR (2003) Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry 54(3):363–375

    Article  Google Scholar 

  3. Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC et al (2008) Clinical correlates of depressive symptoms in familial Parkinson’s disease. Mov Disord. 23(15):2216–2223

    Article  Google Scholar 

  4. Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord. 16:507–510

    Article  CAS  Google Scholar 

  5. Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454

    Article  CAS  Google Scholar 

  6. Aarsland D, Pahlhagen S, Ballard CG, Ehrt UE, Svenningsson P (2012) Depression in Parkinson disease–epidemiology, mechanisms and management. Nat Rev Neurol 11:35–47

    Article  Google Scholar 

  7. Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008 Jennifer S.A.M. Reijnders, MA,1 Uwe Ehrt, MD,2 Wim E.J. Weber, MD, PhD,3 Jan) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23(2):183–189

    Article  Google Scholar 

  8. Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord. 15(2):216–223

    Article  CAS  Google Scholar 

  9. Lemke MR (2008) Depressive symptoms in Parkinson’s disease. Eur J Neurol 15(Supple 1):21–25

    Article  Google Scholar 

  10. Burn DJ (2002) Depression in Parkinson’s disease. Eur J Neurol 9(Suppl 1):44–54

    Article  Google Scholar 

  11. Marsh L (2013) Depression and Parkinson’s disease: current knowledge. Curr Neurol Neurosci Rep 13(12):409

    Article  Google Scholar 

  12. Slaughter JR, Slaughter KA, Dave N, Holmes SE, Martens MP (2001) Prevalence, clinical manifestations, aetiology, and treatment of depression in Parkinson's disease. J Neuropsychiatr Clin Neurosci 13:187–196

    Article  CAS  Google Scholar 

  13. Ceylan D, Erer S, Zarifoğlu M, Türkeş N, Özkaya G (2019) Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on Botulinum toxin therapy and their relatives. Neurol Sci 40(4):725–731

    Article  Google Scholar 

  14. Conte A, Berardelli I, Ferrazzano G, Pasquini M, Berardelli A, Fabbrini G (2016) Non-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbances. Parkinsonism Relat Disord 22:S111–S114

    Article  Google Scholar 

  15. Chunling W, Zheng X (2016l) Review on clinical update of essential tremor. Neurol Sci 37(4):495–502

    Article  Google Scholar 

  16. Aslam S, Zhang N, Adler CH, Caviness JN, Driver-Dunckley E, Mehta SH, Sabbagh MN, Belden C, Zamrini E, Beach TG, Shill HA (2017) Essential tremor and depression. Mov Disord Clin Pract 4(6):838–842

    Article  Google Scholar 

  17. Berman BD, Junker J, Shelton E, Sillau S, Jinnah H, Perlmutter JS et al (2017) Psychiatric Associations of Adult-Onset Focal Dystonia Phenotypes. J Neurol Neurosurg Psychiatry 88(7):595–602

    Article  Google Scholar 

  18. Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T (2016) Cervical dystonia and quality of life. Acta Neurol Belg 116(4):589–592

    Article  Google Scholar 

  19. Shulman L, Taback R, Rabinstein A et al (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8:193–197

    Article  CAS  Google Scholar 

  20. Williams JR, Hirsch ES, Anderson K, Bush AL, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone G, Weiss H, Rabins P, Marsh L (2012) A comparison of nine scales to detect depression in Parkinson disease: which scale to use? Neurology. 78(13):998–1006

    Article  CAS  Google Scholar 

  21. Goodarzi Z, Ismail Z (2017) A practical approach to detection and treatment of depression in Parkinson disease and dementia. Neurol Clin Pract 7(2):128–140

    Article  Google Scholar 

  22. Mondolo F, Jahanshahi M, Gran A, Biasutti E, Cacciatori E, Di Benedetto P (2006) The validity of the Hospital Anxiety and Depression Scale and the Geriatric Depression Scale in Parkinson’s disease. Behav Neurol 17(2):109–115

    Article  Google Scholar 

  23. Mitchell AJ, Baker-Glenn EA, Granger L, Symonds P (2009 a Alex J. Mitchell Elena A. Baker-Glenn Lorraine Granger Paul Symonds) Can the distress thermometer be improved by additional mood domains? Part I. Initial validation of the emotional thermometer tool. Psychooncology 19:125–133

    Article  Google Scholar 

  24. Mitchell AJ, Baker-Glenn EA, Park B, Granger L, Symonds P (2009b) Can the distress thermometer be improved by additional mood domains? Part II. What is the optimal combination of emotional thermometers? Psychooncology. 19:134–140

    Article  Google Scholar 

  25. Rampling J, Mitchell AJ, Von-Oertzen T, Docker J, Jackson J, Hannah C et al (2012) Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods. Epilepsia. 53(10):1713–1721

    Article  Google Scholar 

  26. Thompson AGB, Sheldon R, Poole N, Varela R, White S, Jones P et al (2019) A new way of rapidly screening for depression in multiple sclerosis using emotional thermometers. Acta Neuropsychiatr. 31(3):151–158

  27. Cuijpers P, Dekker J, Noteboom A, Smits N, Peen J (2007) Sensitivity and specificity of the major depression inventory in outpatients. BMC Psychiatry 7:39

    Article  Google Scholar 

  28. Jacobsen PB, Donovan KA, Trask PC, Fleishman SB, Zabora J, Baker F, Holland JC (2005) Screening for Psychologic distress in ambulatory cancer patient. A multicenter evaluation of the distress thermometer. Cancer. 103:1494–1502

    Article  Google Scholar 

  29. Youden W (1950) Index for rating diagnostic tests. Cancer 3(1):32–35

    Article  CAS  Google Scholar 

  30. Mitchell AJ (2011) Sensitivity × PPV is a recognized test called the Clinical Utility Index (CUI+). Eur J Epidemiol, Springer Verlag 26(3):251–252

    Article  Google Scholar 

  31. Mitchell AJ, Pezzullo J http://www.clinicalutility.co.uk/. [Online].; 2012 [cited 2018 11 01

  32. Jones SR, Carley S, Harrison M (2003) An introduction to power and sample size estimation. Emerg Med J 20:453–458

    Article  CAS  Google Scholar 

  33. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W (2001) The sensitivity and specificity of the major depression inventory using the present state examination as the index of diagnostic validity. J Affect Disord 66:159–164

    Article  CAS  Google Scholar 

  34. Bech P, Timmerby N, Martiny K, Lunde M, Soendergaard S (2015) Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity. BMC Psychiatry 15(190)

  35. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370

    Article  CAS  Google Scholar 

  36. Verhey F (2001) The psychometric properties of the hospital anxiety and depression scale in patients with Parkinson’s disease. Acta Neuropsychiatr 13(4):83–85

    Google Scholar 

  37. Mitchell AJ. http://www.psycho-oncology.info/ET.htm. [Online]. [cited 2018 Nov 9

  38. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM (2006) Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 5(5):399–405

    Article  Google Scholar 

  39. Gilbody S, Sheldon T, Wessely S (2006) Should we screen for depression? BMJ. 332:1027–1030

    Article  Google Scholar 

  40. McCullough PK (1991) Geriatric depression: atypical presentations, hidden meanings. Geriatrics. 46(10):72–76

    CAS  PubMed  Google Scholar 

  41. Trojano L, Papagno C (2018) Cognitive and behavioral disorders in Parkinson's disease: an update. II: Behavioral Disorders. Neurol Sci 39(1):53–61

    Article  Google Scholar 

  42. Mitchell AJ, Ioannou N, Rampling JM, Sajid A, von Oertzen TJ, Cock HR, Agrawal N (2013) Which symptoms are indicative of depression in epilepsy settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord 150(3):861–867

    Article  Google Scholar 

  43. Ismail Z, Malick A, Smith EE, Schweizer T, Fischer C (2014) Depression versus dementia: is this construct still relevant? Neurodegener Dis Manag 4(2):119–126

    Article  Google Scholar 

  44. den Brok M, van Dalen J, van Gool W, Moll van Charante E, de Bie R, Richard E (2015) Apathy in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 30(6):759–769

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Atkinson Morley Regional Neurosciences Centre, St. George’s Hospital, London, UK

    Parviz Bahadoran, Rita Varela, Andrea De Angelis, Dominic Paviour & Niruj Agrawal

Authors
  1. Parviz Bahadoran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rita Varela
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea De Angelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dominic Paviour
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Niruj Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parviz Bahadoran.

Ethics declarations

Conflict of interest

We have no conflicts of interest to disclose.

Ethical approval

We confirm that all participants have read the study information leaflet, and their questions have been answered prior to providing informed consent to participate in the study. As this project met the criteria for a service development project, a Research Ethical Committee (REC) approval was not required by this NHS committee.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bahadoran, P., Varela, R., De Angelis, A. et al. Screening for depression in movement disorders clinic. Neurol Sci 42, 969–978 (2021). https://doi.org/10.1007/s10072-020-04571-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04571-7

Keywords

Search

Navigation